PwC appoints Issy Corbett as healthcare M&A partner
February 1, 2016Sales and Marketing pwC
PwC has appointed Issy Corbett as a partner to lead its healthcare M&A team.Corbett joins PwC from Rothschild, where he …
Contigency plans in place while Smith & Nephew boss has cancer treatment
February 1, 2016Manufacturing and Production Olivier Bohuon, Smith & Nephew, medical devices
Medical technology firm Smith & Nephew has announced that chief executive Olivier Bohuon has been diagnosed with a ‘highly treatable …
Merck launches health tech start-up program in Africa
February 1, 2016Manufacturing and Production, Medical Communications, Research and Development
Merck has begun its equity-free accelerator program for digital health start-ups in Nairobi, Kenya- a three-month venture offering $15,000 equity-free …
Ministers reject bid to revive Off Patent Drugs Bill
February 1, 2016Research and Development, Sales and Marketing Access to Medical Treatments (Innovation) Bill, Off Patent Drugs Bill, Off-Patent Drugs Bill, george freeman, parliament, repurposing drugs
Ministers have rejected amendments to a proposed Parliamentary Bill that sought to reintroduce elements of the Off Patent Drugs Bill, …
Actelion’s Uptravi and rare bleeding disorder drug get positive EMA decisions
February 1, 2016Sales and Marketing CHMP, EMA, Uptravi, pulmonary arterial hypertension, selexipag
The Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the EMA, has issued positive opinions on …
EMA fast-tracks BMS multiple myeloma drug
February 1, 2016Sales and Marketing AbbVie, BMS, Bristol-Myers Squibb, EMA, Empliciti, myeloma
The EMA has recommended granting a marketing authorisation for Bristol Myers-Squibb and AbbVie’s immunotherapy Empliciti for the treatment of multiple myeloma. The …
Gilead Sciences names John Milligan new CEO
January 29, 2016Medical Communications, Sales and Marketing Gilead Sciences, John Martin, John Milligan
Gilead Sciences has announced that chairman and chief executive John Martin is to step down after 20 years at the …
Allergan’s depression drug awarded FDA Breakthrough Therapy status
January 29, 2016Research and Development, Sales and Marketing Allergan, depression, rapastinel
While still adjusting to life as part of Pfizer, Allergan has received some good news in the form of the …
Pharma: How to make mergers work
January 29, 2016Sales and Marketing mergers and acquisitions
Pharma is no stranger to bursts of M&A activity.
Regulation of drug promotion ‘should be toughened up’, study finds
January 29, 2016Medical Communications ABPI Code, Department of Justice, PMCPA, Prescription Medicines Code of Practice Authority, Sunshine Act, marketing, off label, off-label, promotion
The voluntary code of conduct system that regulates the pharma industry’s promotion of off-label prescribing has a ‘limited capacity’ to …
MSD gets FDA approval for hepatitis C drug Zepatier
January 29, 2016Medical Communications, Sales and Marketing FDA, MSD, Zepatier, hepatitis C
The competitive hepatitis C market is to get another contender, with FDA approving MSD’s new combo treatment Zepatier (elbasvir and …
FDA plans greater diversity in clinical trials
January 29, 2016Medical Communications, Research and Development FDA, Robert Califf, clinical trial, patient recruitment
The FDA is to focus on increasing patient diversity in clinical trials in 2016, to “ensure that research participants are …
Sanofi expands Iranian presence with memorandum agreement
January 29, 2016Manufacturing and Production, Medical Communications Iran, Sanofi, Serge Weinberg
Sanofi has become the latest pharmaceutical company to expand its presence in post-sanctions Iran, signing a memorandum of co-operation with …
Aslan Pharmaceuticals appoints eminent cancer researcher to chair scientific advisory board
January 28, 2016Research and Development Aslan, Professor Sir David Lane
Aslan Pharmaceuticals has appointed four global cancer experts to its new scientific advisory board.The Board will be chaired by the …
New HR head as Roche makes corporate executive committee changes
January 28, 2016Medical Communications Roche
The Board of Directors has appointed Cristina Wilbur to succeed Silvia Ayyoubi as head of group human resources and member …
BMS says Phase III Opdivo head and neck cancer trial stopped early
January 28, 2016Medical Communications, Research and Development
Bristol Myers Squibb has announced a Phase III study of Opdivo (nivolumab) in head and neck cancer patients was stopped early …
Indian pharma market set to grow to $55 billion by 2020
January 28, 2016Sales and Marketing GlobalData
The pharmaceuticals market in India, valued at $20 billion in 2015, is set to soar to $55 billion by 2020, …
Roche beats estimates with strong 2015 sales
January 28, 2016Medical Communications, Sales and Marketing Esbriet, Herceptin, Roche, avastin
Roche reported full-year financial results today, beating analysts’ estimates, with the Swiss drugmaker announcing Group sales increases for 2015 in …
AZ’s Lynparza gets prostate cancer breakthrough status
January 28, 2016Sales and Marketing AstraZeneca, Breakthrough Therapy Designation, FDA, lynparza, olaparib, prostate cancer
AstraZeneca’s Lynparza has been granted breakthrough therapy designation by the FDA as a monotherapy for the treatment of a specific …
Lilly and Roche team up on new Alzheimer’s diagnostic test
January 28, 2016Research and Development Alzheimer's disease, Diagnostics, Roche, dementia, lilly
Eli Lilly has partnered with Roche Diagnostics to advance its development of a cerebrospinal fluid test for amyloid-beta 1-42, which …
Latest content
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
